-transparent.png){kind=logo}
In a randomized clinical study, 32 patients with Sjögrens syndrome (SS) were given placebo/bromhexine (Bisolvon) 48 mg daily for 3 weeks. Various ophthalmological and oral variables as well as different proteins in tear fluid and saliva were registered. Bromhexine stimulated the tear secretion significantly, presumably without changing the protein composition of the tear fluid. In saliva the IgM concentration in contrast to other proteins decreased in patients with high pre-treatment values. Bromhexine may be of valuable help in the treatment of some patients with SS.
Related Publications
J U Prause, and
K Frost-Larsen, and
L Høj, and
H Isager, and
R Manthorpe
January 1968,
Reumatismo,
J U Prause, and
K Frost-Larsen, and
L Høj, and
H Isager, and
R Manthorpe
August 1978,
British medical journal,
J U Prause, and
K Frost-Larsen, and
L Høj, and
H Isager, and
R Manthorpe
August 1989,
Journal of autoimmunity,
J U Prause, and
K Frost-Larsen, and
L Høj, and
H Isager, and
R Manthorpe
January 1993,
Annales de medecine interne,
J U Prause, and
K Frost-Larsen, and
L Høj, and
H Isager, and
R Manthorpe
October 1958,
Lancet (London, England),
J U Prause, and
K Frost-Larsen, and
L Høj, and
H Isager, and
R Manthorpe
October 1979,
British medical journal,
J U Prause, and
K Frost-Larsen, and
L Høj, and
H Isager, and
R Manthorpe
June 1981,
Israel journal of medical sciences,
J U Prause, and
K Frost-Larsen, and
L Høj, and
H Isager, and
R Manthorpe
September 2003,
Archives of otolaryngology--head & neck surgery,
J U Prause, and
K Frost-Larsen, and
L Høj, and
H Isager, and
R Manthorpe
January 2008,
Swedish dental journal,
J U Prause, and
K Frost-Larsen, and
L Høj, and
H Isager, and
R Manthorpe
February 1979,
Ryumachi. [Rheumatism],
